These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3346109)

  • 1. Changes in plasma gangliosides in relation to tumor growth and their tumor-enhancing effect.
    Saha S; Chattopadhyay U
    Int J Cancer; 1988 Mar; 41(3):432-5. PubMed ID: 3346109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in plasma gangliosides in relation to tumor growth modified by vitamin A.
    Saha S; Ghosh A
    Cancer Lett; 1991 Mar; 56(3):251-8. PubMed ID: 2021929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of plasma gangliosides on the growth of Ehrlich ascites tumor.
    Saha S; Ghosh A
    Int J Cancer; 1990 Oct; 46(4):691-4. PubMed ID: 2210885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of Ehrlich subcutaneous solid tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype antibody.
    Saha S; Mondal S
    J Exp Clin Cancer Res; 2001 Mar; 20(1):75-84. PubMed ID: 11370834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of Ehrlich ascites tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype of the anti-GT1b IgM.
    Saha S; Mondal S
    Indian J Exp Biol; 2000 Dec; 38(12):1207-16. PubMed ID: 11411041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of subcutaneous growth of Ehrlich ascites carcinoma (EAC) tumor by post-immunization with EAC-cell gangliosides and its anti-idiotype antibody in relation to tumor angiogenesis, apoptosis, cell cycle and infiltration of CD4+, CD8+ lymphocytes, NK cells, suppressor cells and APC-cells in tumor.
    Mondal B; Saha S
    Indian J Exp Biol; 2011 Aug; 49(8):574-84. PubMed ID: 21870425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation and modulation of Ehrlich ascites tumor growth with tumor-plasma IgA.
    Ghosh AK; Saha S
    Indian J Exp Biol; 2000 Apr; 38(4):313-22. PubMed ID: 11218806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between the ganglioside composition of Ehrlich ascitic carcinoma and cell population density].
    Prokazova NV; Kocharov SL; Zvezdina ND; Shaposhnikova GI; Buznikov GA
    Biokhimiia; 1978 Oct; 43(10):1805-8. PubMed ID: 719051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascitic versus solid growth of Ehrlich ascites tumor influenced by immunological factors.
    Culo F; Allegretti N; Marusić M
    Oncology; 1978; 35(1):15-21. PubMed ID: 625393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive immunotherapy of mice bearing Ehrlich ascites tumor expressing human, membrane-bound placental alkaline phosphatase.
    Barka T; Henderson S; van der Noen HM
    Tumour Biol; 2000; 21(3):145-52. PubMed ID: 10754465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
    Olinescu A; Hristescu S; Mazilu E
    Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in the RNA content of the blood plasma in rats with Ehrlich ascitic cancer].
    Agliullina DG; Lapina LA; Vinter VG
    Eksp Onkol; 1988; 10(4):49-51, 62. PubMed ID: 2460309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-specific changes in mouse serum during Ehrlich carcinoma growth.
    Sitdikova SM; Amandzholov BS; Sel'chuk VY; Donenko FV
    Bull Exp Biol Med; 2003 Jun; 135(6):576-9. PubMed ID: 12937678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to Ehrlich ascites tumor in a strain of dystrophic mice.
    Carry PJ; Prescott DM; Ogilvie GK
    Cancer Res; 1979 Jun; 39(6 Pt 1):2139-40. PubMed ID: 445411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood ammonia in mice bearing Ehrlich ascites tumors].
    Carrascosa JM; Martínez P; Núñez de Castro I
    Rev Esp Fisiol; 1982; 38 Suppl():195-8. PubMed ID: 7146577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on haematological changes during immunization of mice against transplantable tumour.
    Das A; Roy DK
    Indian J Exp Biol; 1980 Nov; 18(11):1349-51. PubMed ID: 7216301
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in the immunobiologic properties of Ehrlich ascites carcinoma under the effect of suspension from normal rat tissues. I. Heterotransplantation of Ehrlich ascites carcinoma].
    Novikov DK
    Tsitologiia; 1965; 7(3):420-3. PubMed ID: 5879870
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of nonspecific immune stimulation with BCG and polidin on the Ehrlich ascites tumor growth.
    Todoruţiu-Papilian C; Daicoviciu D; Mulea R; Rişcă R
    Morphol Embryol (Bucur); 1985; 31(3):217-25. PubMed ID: 2931598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of ascitic fluid on the growth of Ehrlich tumor and Lewis carcinoma].
    Donenko FV; Kabieva AO; Moroz LV
    Biull Eksp Biol Med; 1992 Jul; 114(8):191-3. PubMed ID: 1467491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of level of gangliosides in plasma with cancer in human patients.
    Mondal S; Saha S
    J Exp Clin Cancer Res; 2000 Sep; 19(3):317-27. PubMed ID: 11144525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.